AbbVie Header AbbVie Header

X

CAS 452339-73-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 452339-73-0
Also known as: 452339-73-0, (r)-5-(2,2-dimethyl-4h-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one, 2-oxazolidinone, 5-(2,2-dimethyl-4h-1,3-benzodioxin-6-yl)-, (5r)-, (5r)-2-oxazolidinone, 5-(2,2-dimethyl-4h-1,3-benzodioxin-6-yl), Schembl925446, Dtxsid601164190
Molecular Formula
C13H15NO4
Molecular Weight
249.26  g/mol
InChI Key
JUEBDVANOFZMMX-NSHDSACASA-N

1 2D Structure

CAS 452339-73-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
2.1.2 InChI
InChI=1S/C13H15NO4/c1-13(2)16-7-9-5-8(3-4-10(9)18-13)11-6-14-12(15)17-11/h3-5,11H,6-7H2,1-2H3,(H,14,15)/t11-/m0/s1
2.1.3 InChI Key
JUEBDVANOFZMMX-NSHDSACASA-N
2.1.4 Canonical SMILES
CC1(OCC2=C(O1)C=CC(=C2)C3CNC(=O)O3)C
2.1.5 Isomeric SMILES
CC1(OCC2=C(O1)C=CC(=C2)[C@@H]3CNC(=O)O3)C
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 452339-73-0

2. (r)-5-(2,2-dimethyl-4h-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one

3. 2-oxazolidinone, 5-(2,2-dimethyl-4h-1,3-benzodioxin-6-yl)-, (5r)-

4. (5r)-2-oxazolidinone, 5-(2,2-dimethyl-4h-1,3-benzodioxin-6-yl)

5. Schembl925446

6. Dtxsid601164190

7. Amy30026

8. Bcp24279

9. Cs-m2588

10. Cta33973

11. (5r)-5-(2,2-dimethyl-4h-1,3-benzodioxin-6-yl)-2-oxazolidinone

12. Mfcd21362968

13. Zinc34571268

14. Ac-30866

15. Ds-12375

16. F11523

17. A852183

18. (5r)-5-(2.2-dimethyl-4h-1.3-benzodioxin-6-yl)-1.3-oxazolidin-2-one

19. (r)-5-(2,2-dimethyl-4h-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one

20. (5r)-5-(2,2-dimethyl-2,4-dihydro-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one

2.3 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 249.26 g/mol
Molecular Formula C13H15NO4
XLogP31.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass249.10010796 g/mol
Monoisotopic Mass249.10010796 g/mol
Topological Polar Surface Area56.8 Ų
Heavy Atom Count18
Formal Charge0
Complexity344
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
503070-57-3
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY